Publication | Closed Access
PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitors
32
Citations
27
References
2015
Year
Cancer ImmunosurveillanceMedicineImmunologyPeripheral Blood TEgfr InhibitorsBronchial NeoplasmImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyLung Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1